Stergios Kechagias
Professor
Professor in internal medicine
Research on metabolic dysfunction-associated steatotic liver disease (MASLD)
MASLD has become the most common liver disease affecting adults and children.
Our research purposes are to further characterize the natural history of MASLD, identify factors that influence the progression of MASLD, and to develop and validate diagnostic methods for MASLD.
Publications
2026
Pharmacokinetic modelling of MRI-based liver function for risk assessment in primary sclerosing cholangitis: a prospective pilot study
European Radiology Experimental, Vol. 10, Article 91
(Article in journal)
https://dx.doi.org/10.1186/s41747-026-00764-5
Fibroblast activation protein and down-stream effects on its substrates in metabolic dysfunction-associated steatotic liver disease
Scandinavian Journal of Gastroenterology
(Article in journal)
https://dx.doi.org/10.1080/00365521.2026.2679101
Clinical relevance and reproducibility of morphological MRI findings in liver cirrhosis: Results from ACCESS-ESLD
European Journal of Radiology, Vol. 200, Article 112845
(Article in journal)
https://dx.doi.org/10.1016/j.ejrad.2026.112845
Chronic Liver Disease: Assessing Inflammation and Fibrosis Using Three‐Dimensional MR Elastography With Same‐Day Biopsy in a Prospective Cohort
Journal of Magnetic Resonance Imaging, Vol. 64, p. 306-319, Article jmri.70319
(Article in journal)
https://dx.doi.org/10.1002/jmri.70319
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD
Clinical Gastroenterology and Hepatology, Vol. 24, p. 394-406
(Article in journal)
https://dx.doi.org/10.1016/j.cgh.2025.07.011
News
Research group
Publications
Selected publications
Patrik Nasr, Mikael F. Forsgren, Simone Ignatova, Nils Dahlström, Gunnar Cedersund, Olof Dahlqvist Leinhard, Bengt Norén, Mattias Ekstedt, Peter Lundberg, Stergios Kechagias
(2017)
Gastroenterology
, Vol.153
, s.53-+
Continue to DOI
Recent publications
2026
Pharmacokinetic modelling of MRI-based liver function for risk assessment in primary sclerosing cholangitis: a prospective pilot study
European Radiology Experimental, Vol. 10, Article 91
(Article in journal)
https://dx.doi.org/10.1186/s41747-026-00764-5
Fibroblast activation protein and down-stream effects on its substrates in metabolic dysfunction-associated steatotic liver disease
Scandinavian Journal of Gastroenterology
(Article in journal)
https://dx.doi.org/10.1080/00365521.2026.2679101
Clinical relevance and reproducibility of morphological MRI findings in liver cirrhosis: Results from ACCESS-ESLD
European Journal of Radiology, Vol. 200, Article 112845
(Article in journal)
https://dx.doi.org/10.1016/j.ejrad.2026.112845
Chronic Liver Disease: Assessing Inflammation and Fibrosis Using Three‐Dimensional MR Elastography With Same‐Day Biopsy in a Prospective Cohort
Journal of Magnetic Resonance Imaging, Vol. 64, p. 306-319, Article jmri.70319
(Article in journal)
https://dx.doi.org/10.1002/jmri.70319
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD
Clinical Gastroenterology and Hepatology, Vol. 24, p. 394-406
(Article in journal)
https://dx.doi.org/10.1016/j.cgh.2025.07.011
About me
CV
- Reg. Physician 1996
- PhD 2001
- Professor 2013
Teaching
- The Medical Program
Awards
- Pedagogue of the Year, 2017
- Bergdahl Award, 2022